Excellence Award

P.0314
The role of eukaryotic elongation factor 1 A proteins at synapses and in synucleinopathy
Sarka Jelinkova, France

P.0207
Major psychiatric complications of psychedelic drug use: a systematic review of case reports
Betül Yildirim, Türkiye

P.0337
Prenatal antidepressant exposure and offspring brain morphology trajectories: a longitudinal population-based mri study
Dogukan Koc, The Netherlands

P.0338
Risk factors and consequences of traumatic brain injury in a Swiss male population cohort
Alexandru Pavel, Romania

P.0394
Using machine learning to improve pathways for precision medicine in psychiatry
Paris Alexandros Lalousis, United Kingdom

P.0216
Treatment adherence in forensic patients with schizophrenia spectrum disorders discharged on long-acting injectable antipsychotics – a comparative three-year mirror-image study
Yasin Hasan Balcioglu, Türkiye

P.0253
Evaluation of circadian clock proteins and the effect of continuous positive airway pressure (CPAP) treatment among obstructive sleep apnea patients
Agata Gabryelska, Poland

P.0371
Effects of ketamine and lamotrigine on negative emotional processing in the brain: a double-blind randomized controlled neuroimaging study
Marvin Meiering, Germany

P.0186
The role of microglia and progranulin in the pathophysiology of frontotemporal dementia
Marc-Philipp Weyer, Germany

P.0199
Borderline personality disorder: clinical and inflammatory features
Nadia Cattane, Italy

P.0076
Psilocybin as a treatment for anorexia nervosa: 6-week and 3-month follow-up results
Hannah Douglass, United Kingdom

P.0381
Relationship between heart rate variability and impulse control, emotion regulation, cognitive flexibility, magical ideation in controls, and major depression patients
Hayri Can Ozden, Türkiye

P.0325
Prenatal infection causes increased general anxiety in early adult rats both sexes, but has no effect on memory or sociability
Marina Manojlović, Serbia

P.0112
Pharmacogenomic-guided therapy for the improvement of antidepressant treatment outcomes: systematic review and meta-analysis of current evidence from randomised controlled trials
Filip Milosavljević, Serbia

P.0328
A generalizable normative deep learning approach for the discrimination of psychiatric disorders based on neuroanatomy
Inês Sampaio, Italy

P.0382
Elevated resting-state EEG gamma-band power in schizophrenia
Özge Akgül, Türkiye

P.0118
Mitochondrial DNA copy number, oxidation, and D-loop methylation alterations in acute or remission phases of unipolar and bipolar depression
Deniz Ceylan, Türkiye

P.0119
Increased oxidative DNA damage and altered base excision repair mechanisms in bipolar disorder and individuals at risk for bipolar disorder
Hidayet Ece Çelik, Türkiye

P.0121
Decreased mitochondrial copy number in individuals with bipolar disorder and their unaffected siblings
Izel Cemre Akşahin, Türkiye

P.0326
Anethole prevents high-calorie diet-induced brain lipid peroxidation in rats and normalizes superoxide dismutase activity
Elis Rafailova, Bulgaria

P.0063
Frequency and associated features of phantom phone signaling syndrome in youth applying to the psychiatry clinic
Zehra Uçar Hasanlı, Türkiye

P.0126
White matter microstructure in major depressive disorder is associated with lymphocyte count: differential effects of childhood maltreatment
Susanne Meinert, Germany

P.0286
Fall prevention through vestibular perceptual learning
Matthias Ertl, Switzerland

P.0330
Alterations of functional connectivity dynamics in affective and psychotic disorders
Linnea Hoheisel, Germany

P.0148
Human monocytes of patients with depression and inflammation, transdifferentiated into neuronal-like cells, show hyperresponsiveness to inflammatory stimulation
Susanne Schillo, Germany

P.0584
Altered salience/sensorimotor network activation during emotional processing in non-responders to paroxetine treatment with depression
Rita Vieira, Portugal

P.0780
Electroconvulsive therapy improves somatic symptoms before mood in patients with depression: a directed network approach
Emma De Schuyteneer, Belgium

P.0598
Structural brain network connectivity mediates the association between polygenic score for tumor necrosis factor-α and processing speed in acute depression
Jonathan Repple, Germany

P.0761
Virtual reality-based training for improvement of cognitive functioning for healthy older adults – preliminary results
Ewa Szczepocka, Poland

P.0630
Machine learning model to estimate mortality risk after the first episode of bipolar disorder
Johannes Lieslehto, Finland

P.0635
A novel marker of interleukin 6 activity and clinical and cognitive outcomes in depression
Éimear M Foley, United Kingdom

P.0788
Pharmacological treatment of psychotic depression: a systematic review and network meta-analysis
Chiara Possidente, Italy

P.0663
Steroid-responsive catatonia associated with possible autoimmune enchephalitis – a case series
Rifat Serav Ilhan, Türkiye

P.0571
Smartphone app-induced habit: a therapeutic component in psychological treatment for obsessive-compulsive disorder
Ana Maria Frota Lisboa Pereira De Souza, United Kingdom

P.0693
Unique contribution of neurotransmitter maps for predicting cerebral blood flow alterations in schizophrenia and the clinical high-risk state for psychosis
Samuel Knight, United Kingdom

P.0807
Schizophrenia-like behavior in an RNA binding motif 12 (RBM12) zebrafish model
Elena Richert, Iceland

P.0784
Electroconvulsive therapy – charge and frequency relate to therapeutic outcome
Kaan Keskin, Türkiye

P.0808
Angiotensin-converting enzyme type 2 blockade affects behavior, motor coordination, and thermal nociception in mice
Filippos - Savvas Chelmis, Bulgaria

P.0702
MRI-based cortical gray/white matter contrast in individuals with clinical or genetic risk for psychosis
Nasimeh Naseri, Norway

P.0740
Poor sleep quality is associated with abnormal white matter structure in psychotic disorders
Umit Haluk Yesilkaya, Türkiye

P.0838
Are genetics underpinning the increased risk of SARS-CoV-2 infection in people with mental disorders?
Anna Monistrol-Mula, Spain

P.0713
The effect of electroconvulsive treatment on inflammatory indices in major psychiatric disorders
Amine Kilictutan, Türkiye

P.0748
Nuclei-specific hypothalamus networks predict a dimensional marker of stress in humans
Daria EA Jensen, Germany

P.0839
Dropout of prescribed psychotherapeutic treatment among patients with anxiety disorders or major depression within the capital region of Denmark
Frederikke Hørdam-Gronemann, Denmark

P.0813
Hyperlipidemia affects synaptic integrity in the hippocampus but not cerebral cortex
Büşranur Şeker, Türkiye

P.0814
Bempedoic acid attenuates cognitive impairment and depression-like behavior in middle-aged rats
Gülşen Çelebi, Türkiye

P.0816
Social environment affects the vulnerability to adolescent-onset depression and determines antidepressant efficacy in a preclinical model
Naomi Ciano Albanese, Italy

P.0548
Effects of cannabidiol on fear conditioning in anxiety disorders: interactions with sex and antidepressant use but no enhanced fear extinction
Caroline Kwee, The Netherlands

P.0753
Gut microbiota regulates diurnal oscillations in stress responsiveness
Gabriel Tofani, Ireland

P.0819
CYP2C19 in the developing brain of transgenic humanised knock-in mouse causes morphological changes in the cerebellum, including 11.8% atrophy
Andrea Atanasov, Serbia

P.0823
Social recognition, short-term and long-term object recognition memory in CYP2C19 humanised transgenic mice
Vesna Pesic, Serbia

P.0754
The virome regulates the effects of chronic stress in mice
Nathaniel L. Ritz, Ireland

P.0858
Differences in mitochondrial DNA copy number between major depressive disorder, bipolar disorder and schizophrenia: a meta-analysis
Sevin Hun Senol, Türkiye

P.0831
Exploring psychiatric conditions through machine learning: a comprehensive analysis of large-scale data from the ECNP data network
Adyasha Khuntia, Germany

P.1090
Ketamine and the 5-HT1A receptor biased agonists, NLX-204 and NLX-101, share common cortical efficacious rapid acting antidepressant mechanisms in rat cms depression model
Piotr Gruca, Poland

P.1099
Impact of personalized dosing guided by plasma level quantification on escitalopram exposure - a cross-sectional study
Aleksandra Jeremic, Serbia

P.1101
Impact of personalised dosing based on quantification of drug plasma levels on the efficacy and safety of treatment with escitalopram
Petar Vuković, Serbia

P.1102
Stable neural underpinnings of emotional cognition subgroups in newly diagnosed patients with bipolar disorder: a prospective fMRI study
Hanne Lie Kjaerstad, Denmark

P.1104
Functional neuroimaging for the differentiation between healthy controls, depressed bipolar and major depressive patients: a machine learning study
Federico Calesella, Italy

P.1293
Etifoxine and nifedipine act synergistically to reduce directly elicited tetanic contractions in vitro
Vesela Kokova, Bulgaria

P.1365
Dynamic functional connectivity of the central autonomic network in major depressive disorder
Federica Goffi, Italy

P.1248
Exposure to prenatal stress and long-lasting effect on microbiome composition and functionality in the offspring: implications for behavioural outcomes
Floriana De Cillis, Italy

P.1072
Reward-related impulsivity as a possible surrogate marker of motivation in aging Sprague-Dawley rats
Jovana Aranđelović, Serbia

P.1252
Temporal signature of large-scale network integration in emotion regulation
Tamara De Kloe, The Netherlands

P.1253
The gut microbiome in psychiatric disorders: a transdiagnostic perspective
Danique Mulder, The Netherlands

P.1170
Sorbitol accumulation in ZDF rat’s brain as new link between diabetes and Alzheimer’s disease?
Pavol Bodo, Slovak Republic

P.1041
Early-stage adverse effects of antidepressant therapy and associated factors in an psychiatry outpatient clinic
Beren Özel, Türkiye

P.1272
The youth baby and child cohort study: automated intracranial volume segmentation in prenatal three-dimensional ultrasound using convolutional neural networks
Sonja De Zwarte, The Netherlands

P.1318
Mice with a genetic loss of vesicular glutamate transporter 3 targeted to 5-hydroxytryptamine neurons show impairments in reward-based learning
L. Sophie Gullino, United Kingdom

P.1014
Investigation of clinical risk factors associated with substance use in adults with ADHD
Berkem Karakoyunlu, Türkiye

P.1375
Cerebral serotonin 2a receptor occupancy of psychedelic and non-psychedelic compounds as measured in vivo in pigs
Clara Aabye Madsen, Denmark

P.1028
Bidirectional longitudinal associations between attention deficit hyperactivity disorder and physical health in a large cohort dataset
Claire Reed, United Kingdom

P.1225
Effort allocation for rewards in first-episode psychosis and first-episode mania
Simge Uzman Özbek, Türkiye

P.1151
Neuroanatomical network basis of memory performance in euthymic bipolar disorder
Andrea Fernandes, Ireland

P.1403
Repeated, 4-week dosing of CPL500036, a novel phosphodiesterase 10A inhibitor, does not induce tolerance to its antipsychotic-like action
Joanna Krzemień, Poland

P.1031
The relationship between iron,iron binding capacity,ferritin levels, and clinical parameters in adults with attention deficit hyperactivity disorder: a case-control study
Bilal Sağlıyan, Türkiye

P.1390
Neurodynamics of empathy and prosociality following serotonergic stimulation with an ayahuasca analogue containing N,N-dimethyltryptamine and harmine in a randomised controlled trial
Helena Aicher, Switzerland

P.1405
Study of (S)-ketamine’s effects on the dopamine dynamics using fiber photometry
Arianna Rizzo, Spain

P.1178
The intersection of the differential brain transcriptome alteration between Covid-19 and Alzheimer’s disease patients
Kamelija Horvatovic, Croatia

P.1160
Depression, anxiety and stress in individuals following the acute phase of Covid-19
Vojislava Bugarski Ignjatović, Serbia

P.1240
The association between exposome score for schizophrenia and metabolic parameters in individuals with schizophrenia and healthy controls
Gamze Erzin, Türkiye

P.0011
Predilection for addiction: is cocaine addiction in your genes’ back pocket?
Graczyk Michal Mateusz, United Kingdom

P.0019
Hevin protein is altered in postmortem brain of alcoholic subjects and in ethanol treated mice’s brain and plasma
Nuñez-delMoral Amaia, Spain

P.0042
Social adolescent stress causes increased general anxiety in male rats and reduced social anxiety in both male and female rats
Manojlović Marina, Serbia

P.0047
Whole transcriptome expression analysis of long terminal repeat elements in children with autism spectrum disorder
Minchev Danail, Bulgaria

P.0051
Moving towards a reliable multimodal predictive model of clinical outcomes in anorexia nervosa
Derissen Mara, Germany

P.0053
Temporal changes of visual attention to high-calorie foods in adolescents with anorexia nervosa: An eye-tracking study
Akcay Elif, Türkiye

P.0079
DNA base excision repair genes in unipolar and bipolar depression
Yılmaz Selda, Türkiye

P.0082
Abelson helper integration site 1 haplotypes and peripheral blood expression associates with lithium response in bipolar patients
Sakrajda Kosma, Poland

P.0083
Functional polymorphism of CLDN5 has stress mediating effect on current depressive symptoms
Gál Zsófia, Hungary

P.0084
The relationship between cognitive functions, childhood traumas and microRNAs associated with major depressive disorder
Mert Alper, Türkiye

P.0091
A machine learning pipeline for efficient differentiation between depressed bipolar disorder and major depressive disorder patients based on structural neuroimaging
Calesella Federico, Italy

P.0093
Predicting antidepressant treatment outcome in major depressive disorder using multi-domain data: A NeuroPharm study
Dam Vibeke Høyrup, Denmark

P.0101
Resting-state fronto-limbic connectivity in unipolar depressive patients as a predictor for sporadic conversion to (hypo)mania
Tajioui Ikrame, The Netherlands

P.0105
Characterizing the course of gray matter volume change from one week to 6 months after electroconvulsive therapy in depressed patients
Laroy Maarten, Belgium

P.0114
CYP2C19 slow metabolizer phenotype is associated with lower antidepressant efficacy and tolerability: clinical study on 102 inpatients
Milosavljević Filip, Serbia

P.0133
Humanized CYP2C19 transgenic mouse as an animal model of cerebellar ataxia
Atanasov Andrea, Serbia

P.0139
Altered CNS–immune system crosstalk and its link to disease severity in multiple sclerosis
Brasanac Jelena, Germany

P.0140
Exosomes obtained from amyloid-beta toxicity applied cells induce Alzheimer's disease-like pathology in the brain of C57BL/6 mice
Kalkan Çakmak Rabia, Türkiye

P.0143
Ghrelin receptor agonist MK-0677 alleviates motor impairments caused by spreading alpha-synuclein aggregation in bilaterally alpha-synuclein fibrils injected mice
Maziarz Katarzyna, Poland

P.0171
A volumetric paradox – Larger basal ganglia in medication-naive first episode psychosis
Yesilkaya Umit Haluk, Türkiye

P.0223
Alpha2-adrenergic receptor blockade in the ventral tegmental area interferes with acquisition but not retrieval of fear memories
Bernacka Joanna, Poland

P.0240
Is there any room for objective cognitive impairment in subjective cognitive decline?
Pavel Alexandru, Romania

P.0244
Effects of single orally administrated different sized microplastic particles – acute toxicity study in adult male rats
Stojanović Zoran, Serbia

P.0252
Acute psilocybin and ketanserin effects on cerebral blood flow: 5-HT2AR neuromodulatory effects in healthy humans
Larsen Kristian, Denmark

P.0269
Investigation of the age-related role of exosomes in the exacerbation of amyloid beta pathology at the molecular level
Sarikamis Bahar, Türkiye

P.0270
Transgenic mice with progressive degeneration of noradrenergic neurons restricted to locus coeruleus present depressive-like behavior and motor disturbances
Rafa-Zablocka Katarzyna, Poland

P.0281
The impairment of expression of the important proteins in some brain areas in diabetes mellitus: the effect of nicotinamide
Tykhonenko Tetiana, Ukraine

P.0314
Concurrent antiepileptic and antipsychotic use moderates lithium’s effects on regional brain volumes: a mega-analysis from the ENIGMA-Bipolar Disorder Working Group
King Sinead, Ireland

P.0325
The early life microbiota-gut-brain-axis: the temporal relation between infant microbial development and subsequent childhood social-emotional development in healthy children
Bloemendaal Mirjam, The Netherlands

P.0330
Neurochemical properties of psilocybin in comparison to ketamine in vivo
Wojtas Adam, Poland

P.0332
Pharmacokinetics and pharmacokinetic-pharmacodynamic relationship of oral psilocybin administration in healthy subjects
Holze Friederike, Switzerland

P.0333
Ketanserin reverses the acute effects of LSD in healthy subjects
Becker Anna M., Switzerland

P.0385
First presentation of Asperger’s syndrome in paediatric patients
Iotu Alexandra-Diana, Romania

P.0391
Topiramate treatment attenuates mood and cognitive disabilities in a model of temporal lobe epilepsy in rats
Shishmanova-Doseva Mihaela, Bulgaria

P.0392
Epigenome-wide DNA methylation in obsessive-compulsive disorder – a case-control study
Schiele Miriam, Germany

P.0397
Effect of anethole on spatial memory in rats on a high-calorie diet
Rafailova Elis, Bulgaria

P.0400
Perceived stress among patients with depression and anxiety in remission during the COVID-19 pandemic
Kamenova Ivayla, Bulgaria

P.0405
Immune-inflammation and structural neuroimaging differentiate bipolar and unipolar depression: a machine learning study
Colombo Federica, Italy

P.0412
Genetic dissection of the clinical heterogeneity of major depressive disorder
Oliva Vincenzo, Italy

P.0414
Pharmacogenetics of CYP2C19 in response and side effects to major depression treatment: a machine learning approach
Calabrò Marco, Italy

P.0415
A neurofunctional proxy of affect intensity provides unbiased support for the monoamine pathway
FreytagVirginie, Switzerland

P.0424
A multicentric multimodal in vivo microscopy MRI study of bipolar disorder reveals axonal loss and demyelination
Sarrazin, Samuel, France

P.0439
Evaluation of the relationship between neurocognitive characteristics and the tract of kynurenine in the offspring of bipolar disorder
Arıcı Sağlıyan, Gökçeçiçek, Türkiye

P.0440
Neurocognition across bipolar disorder phases in comparison with healthy control
Ciftci Elvan, Türkiye

P.0446
The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a phase IIb randomised controlled trial
Hewitt Nilay, United Kingdom

P.0450
A phase 1/2 trial of a vaporized 5-Methoxy-N,N-Dimethyltryptamine formulation, in patients with treatment-resistant depression
Reckweg Johannes, The Netherlands

P.0458
Simvastatin and emotional processing: an experimental medicine study in healthy volunteers
Waters Shona, United Kingdom

P.0484
Investigation of the effects of carvacrol on cognitive functions in postmenopausal hypertensive rats
Ertas Busra, Türkiye

P.0554
Maternal stress affects human milk composition: a potential role in the transmission of maternal psychopathology to child development
Juncker Hannah, The Netherlands

P.0572
Flaxseed oil attenuates trimethyltin-induced neurodegeneration and gliosis in the hippocampus of female rats
Mitrović Nataša, Serbia

P.0573
Effect of complex neuroprotective therapy on functional recovery after stroke
Vorokhta Yurii, Ukraine

P.0575
Transdiagnostic individualised brain texture changes that are associated with symptom severity using contrast feature map
Korda Alexandra, Germany

P.0603
Immunohistochemical evidence that paroxetine discontinuation in mice is associated with increased activation of 5-HT neurons
Collins Helen, United Kingdom

P.0607
Manipulating a brain circuit associated with sociability by a two-recombinase system
Stoller Franziska, Germany

P.0619
Brain based BMIgap as a new tool to correlate obesity and neural alterations – a multicohort study
Khuntia Adyasha, Germany

P.0627
Mapping diagnostic trajectories from the first diagnosis of mental illness in the entire Danish population over two decades
Jørgensen Terese Sara Høj, Denmark

P.0643
Gray matter correlates of childhood maltreatment: investigation of robustness and replicability in a multi-cohort voxel-based analysis of 2952 adults
Goltermann Janik, Germany

P.0670
A human hippocampal transcriptomics-based drug screening approach identifies novel geroneuroprotective candidates
Rock Daniel, United Kingdom

P.0678
Food addiction in the overweight – the role of affective temperaments and eating behaviours
Jovic Jelena, Serbia

P.0724
The aftermath of COVID-19 lockdown – changing trends in eating disorders among children and adolescents in the psychiatry emergency department
Fortea Lydia, Spain

P.0730
Differential white matter involvement in drug-naïve children with obsessive-compulsive disorder and Tourette syndrome
Conte Giulia, Italy

P.0735
Association between CYP2C19 genotype and body weight with escitalopram exposure – a cross sectional study
Jeremic Aleksandra, Serbia

P.0737
Effects of personalized dosing based on drug plasma level quantification on effectiveness and safety of escitalopram treatment
Vuković Petar, Serbia

P.0746
Association between polygenic risk scores for psychiatric disorders and fluoxetine response in children and adolescent patients
Rodríguez Natalia, Spain

P.0749
Neutrophil/lymphocyte ratio is increased in elderly patients with first episode depression, but not in recurrent depression
Łucka Anna, Poland

P.0750
The effect of transcutaneous vagus nerve stimulation on interleukin 6 and c-reactive protein during stress in depression
Schiweck Carmen, Germany

P.0751
Different relationship of neurological and non-neurological conditions with non-suicidal self-injury among youth with emotional disorders
Lero Marija, Serbia

P.0767
Dynamics of depressive disorders in children and adolescents during COVID-19 pandemic
Andrei Lucia Emanuela, Romania

P.0777
Initiation of antidepressant treatment and the risk of manic episodes in pediatric unipolar depression
Virtanen Suvi, Sweden

P.0792
Pregnancy and postpartum period associated severe mental disorders in a hospital-based cohort
Büyüktopcu Emiralp, Türkiye

P.0805
Age-dependent analysis of the pro- and anti-inflammatory factors gene expression in the brain of the genetically modified knock-in mice APPNL-F/NL-F
Tylek Kinga, Poland

P.0809
Single, conditional, lentiviral CRISPR/Cas9 vectors for efficient mutagenesis in neurons – a possible new strategy for modeling prodromal Parkinson’s disease
Barut Justyna, Poland

P.0819
CPL500036 – a novel inhibitor of phosphodiesterase 10A – attenuates the development of L-DOPA-induced dyskinesias in 6-OHDA lesioned rats
Matłoka Mikołaj, Poland

P.0831
Altered volumes of the amygdala and hippocampus in the suicidal brain of patients with first episode psychosis
Sen Meltem, Türkiye

P.0876
Reduced amygdala volume mediates the association between developmental trauma and psychotic experiences in adulthood – findings from a population-based cohort
Jung Paul Gu-Yun, United Kingdom

P.0882
Salivary cortisol levels in relation to depression and anxiety symptoms in healthy volunteers following a chronic stress period
Kolcsar Melinda, Romania

P.0890
Evaluation of modulatory effect of β1-adrenergic receptor blockade during chronic restraint stress on glutamate transmission in frontal cortex of rats
Zelek-Molik Agnieszka, Poland

P.0908
Intrinsic causal network dynamics of emotion regulation tendency – high and low reappraisal tendency reflected in resting-state fMRI data
Hajrić, Mirna, Austria

P.0909
Multivariate relationships among social stressors and functional brain connectivity – a transdiagnostic dimensional approach
Maggioni Eleonora, Italy

P.0949
Repetitive stimulation of lateral and/or perifornical hypothalamus elevates CSF orexin-A, shortens coma time; accelerates wakefulness and sleep recoveries in rats
Bejanishvili Khatuna, Georgia

P.0956
From neurogenesis to immune response: how neural stem cells switch fate to communicate with immune cells
Nissen Tinne, United Kingdom

P.0965
Differences in patterns of stimulant use and their impact on first-episode psychosis incidence – an analysis of the EUGEI study
Rodríguez-Toscano Elisa, Spain

P.032 
Cannabidiol-mediated effects on behavioural and gene expression changes induced by a new animal model of spontaneous cocaine withdrawal
Ani Gasparyan, Spain

P.047
White matter microstructure and attention-deficit/hyperactivity symptoms: cross-sectional and longitudinal effects
Christienne Damatac, The Netherlands

P.124
Linking functional and structural brain organisation in autism spectrum disorder
Natalie Forde, The Netherlands

P.160
Associations between selective serotonin reuptake inhibitors and violent crime in adolescents, young, and older adults - a Swedish register-based study
Tyra Lagerberg, Sweden

P.179
Polygenic risk scores for multiple psychiatric, inflammatory and cardio-metabolic traits highlight possible genetic overlap with suicide attempt
Giuseppe Fanelli, Italy

P.204
Behavioural and neural correlates of response inhibition in disruptive behaviour disorders
Gulhan Saracaydin, The Netherlands

P.223
Link between Serotonin 4 receptor brain binding and cognitive disturbances in major depressive disorder: a NeuroPharm study
Vibeke Høyrup Dam, Denmark

P.233
A psychobiotic diet decreases stress and depressive mood in healthy volunteers
Kirsten Berding,Ireland

P.238
Lithium treatment modulates the expression of inflammation involved genes in major depressive disorder
Kosma Sakrajda, Poland

P.253
Immunoassay quantification and neuroimaging data for differentiating bipolar and unipolar depression: support vector machine on kernels and elastic net approaches
Benedetta Vai, Italy

P.284
Neuroimaging evidence for increased neurite density in patients with bipolar disorder taking lithium: a replication study.
Samuel Sarrazin, France

P.298
Emotional cognition heterogeneity in patients with mood disorders and clinical implication
Cristina Varo, Spain

P.392
Cerebellar influence on the thalamo-prefrontal firing patterns during fear extinction
Ioana Antoaneta Georgescu, Romania

P.404
Cognitions and their associated neuronal substrates as mediating mechanism between dark personality and antisocial behaviour
Luna Rabl, Austria

P.426
Circadian variation of migraine attack onset influences brain activity during emotion processing - an fMRI study
Daniel Baksa, Hungary

P.443
Altered functional connectivity during combined sequential motor learning and one-week escitalopram administration
Eoin Molloy, Germany

P.452
Lithium in the prevention of relapse following successful electroconvulsive therapy for major depression: a systematic review and meta-analysis
Simon Lambrichts, Belgium

P.499
Ketamine’s influence on global resting-state functional connectivity and individual variation in neuro-behavioural relationships
Flora Moujaes, Switzerland

P.504
Targeting nitric oxide synthase 1 adaptor protein interactions as a possible treatment for schizophrenia: an initial proof-of-concept study in mice
Dilhan Esen-Sehir, Germany

P.507
Machine learning classification of first-episode psychosis using cortical thickness: a large multicenter magnetic resonance imaging study
Alessandro Pigoni, Italy

P.523
Neuromelanin MRI as biomarker for treatment resistance in first episode schizophrenia patients
Marieke Van Der Pluijm , The Netherlands

P.525
The relationship between synaptic density marker SV2A and glutamate: a multimodal positron emission tomography and magnetic resonance spectroscopy imaging study
Ellis Chika Onwordi, United Kingdom

P.540
Modelling the effects of maternal immune activation on early neurodevelopment using a human induced pluripotent stem cell derived system
Amalie Couch, United Kingdom

P.580
Metabolic predictors for mortality among clozapine–treated schizophrenia patients. An Israeli nationwide longitudinal study
Sharon Taub, Israel

P.598
Role of microRNAs in the mechanisms underlying stress vulnerability and resilience
Nadia Cattane, Italy

P.639
The individual’s personal experience of the living environment affects serotoninergic antidepressant treatment outcome
Naomi Ciano Albanese,Italy

P.660
The impact of the Covid-19 pandemic on mental health in a community-based population in Portugal: a case-control observational study
Gonçalo Santos, Portugal

P.661
Psychological impact of the Covid-19 outbreak and lockdown in Spanish sample with anxiety disorder: differences according to sex
Mercedes Valtueña García, Spain

P.711
The clinical and therapeutic challenges of comorbid obsessive-compulsive disorder and bipolar disorder in children and adolescents
Nádia Almeida Barradas, Portugal

P.721
Metabolomic profiles discriminating anxiety from depression
Hilde De Kluiver, The Netherlands

P.730
Characteristics of inflammation-related depression
Éimear M Foley, United Kingdom

P.772
Polysialic acid mimetics to target extrasynaptic NMDA receptors and rescue learning and memory in mouse models of neurodegenerative diseases
Shaobo Jia, Germany

P.777
Neurobiological correlates of antisocial behavior across adolescence: A multi-sample, multi-method study
Neeltje Blankenstein, The Netherlands

P.786
An increase in central nervous system signaling proteins as a criterion for the severity of schizophrenia
Elena Dmitrieva, Russia

P.804
A single dose of psilocybin increases synaptic density and decreases 5-HT2A receptor density in the pig brain
Nakul Ravi Raval, Denmark

P.810
Real-world effectiveness of mood stabilizer use in persons with schizophrenia
Arto Puranen, Finland

P.831
Trajectories of suicidal ideation after a first-episode psychosis: a growth mixture modeling approach
Estela Salagre,Spain

P.861
Gender-specific involvement of Methyl-CpG binding protein 2 in vulnerability to stress: evidence from a healthy cohort
Livia Cosentino, Italy

P.865
Consequences of a single social defeat on accumbal dopamine measures: in vivo voltammetric study
Vsevolod Nemets, Russia

P.867
Effects of etifoxine on general but not stress related expression of the translocator protein 18kDa (TSPO) in healthy subjects
Lisa-Marie Bahr, Germany